menu
    • menu

    Company profile for Rona Therapeutics

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2021 and Stella SHI, CEO and co-founder, Rona Therapeutics aims to establish innovative RNA medicines with proprietary platform to enable therapeutics with more specific, stable and prolonged effects. Its RNA medicines are modular and programmable modalities targeting disease areas across metabolic diseases, neurological diseases and ophthalmology diseases via different delivery systems. The company is building faci...
    Founded in 2021 and Stella SHI, CEO and co-founder, Rona Therapeutics aims to establish innovative RNA medicines with proprietary platform to enable therapeutics with more specific, stable and prolonged effects. Its RNA medicines are modular and programmable modalities targeting disease areas across metabolic diseases, neurological diseases and ophthalmology diseases via different delivery systems. The company is building facilities to expand nucleic acid synthesis, delivery platform, oligonucleotide chemical modification, RNA biology and manufacturing capability to realize the potential of powerful RNA therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rona TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    Room 1308, Caliun Road, Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.ronatherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rona Therapeutics Launches First Global Bi-Valent PCSK9-LPA
    Rona Therapeutics Launches First Global Bi-Valent PCSK9-LPA

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rona-therapeutics-unveils-the-global-first-bi-valent-pcsk9-lpa-sirna-into-clinical-development-for-cardiovascular-risk-reduction-302644507.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    Rona Therapeutics Progresses INHBE Sirna To Phase 1 Trial
    Rona Therapeutics Progresses INHBE Sirna To Phase 1 Trial

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rona-therapeutics-advances-inhbe-sirna-into-phase-1-clinical-development-302642053.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    Rona Submits IND for GalNAc-Conjugated siRNA Targeting Obesity
    Rona Submits IND for GalNAc-Conjugated siRNA Targeting Obesity

    16 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/rona-submits-ind-for-galnac-conjugated-sirna-targeting-obesity-17801

    INDPHARMAPOST
    16 Sep 2025
    Share Share
    Rona Therapeutics Announces IND Filing of RN3161 for Obesity
    Rona Therapeutics Announces IND Filing of RN3161 for Obesity

    16 Sep 2025

    // #N/A

    https://www.expresspharma.in/rona-therapeutics-announces-ind-filing-of-rn3161-for-obesity/

    #N/A
    16 Sep 2025
    Share Share
    Rona Therapeutics Files IND for Potent Obesity Drug RN3161
    Rona Therapeutics Files IND for Potent Obesity Drug RN3161

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rona-therapeutics-announces-ind-filing-of-rn3161-a-highly-potent-and-durable-inhbe-sirna-for-obesity-302555712.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    Rona Therapeutics Reveals Breakthrough Data on RNAi Therapy RN026
    Rona Therapeutics Reveals Breakthrough Data on RNAi Therapy RN026

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rona-therapeutics-announces-breakthrough-data-on-potential-annual-dosing-rnai-therapy-rn026-targeting-lipoproteina-in-the-national-lipid-association-nla-scientific-sessions-2025-302467821.html

    PR NEWSWIRE
    28 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search